{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:34:13Z","timestamp":1787045653752,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Tianjin Health and Wellness Science and Technology Foundation Project","award":["TJWJ2024ZD007"],"award-info":[{"award-number":["TJWJ2024ZD007"]}]},{"name":"Tianjin Key Medical Discipline Construction Project","award":["TJYXZDXK-3-032C"],"award-info":[{"award-number":["TJYXZDXK-3-032C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"DOI":"10.1007\/s00408-026-00922-x","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:23:31Z","timestamp":1787045011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Relevance of Serum Inducible and Endothelial Nitric Oxide Synthase Ratio for Pulmonary Hypertension in Acute Exacerbated Chronic Obstructive Pulmonary Disease"],"prefix":"10.1007","volume":"204","author":[{"given":"Yating","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"922_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-981-15-1792-1_24","volume":"1228","author":"G Fiorentino","year":"2020","unstructured":"Fiorentino G, Esquinas AM, Annunziata A (2020) Exercise and chronic obstructive pulmonary disease (COPD). Adv Exp Med Biol 1228:355\u2013368. https:\/\/doi.org\/10.1007\/978-981-15-1792-1_24","journal-title":"Adv Exp Med Biol"},{"key":"922_CR2","doi-asserted-by":"publisher","first-page":"L879","DOI":"10.1152\/ajplung.00429.2020","volume":"319","author":"A Agusti","year":"2020","unstructured":"Agusti A, Vogelmeier C, Faner R (2020) COPD 2020: changes and challenges. Am J Physiol Lung Cell Mol Physiol 319:L879\u2013L883. https:\/\/doi.org\/10.1152\/ajplung.00429.2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"922_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/resp.14489","volume":"28","author":"PMA Calverley","year":"2023","unstructured":"Calverley PMA, Walker PP (2023) Contemporary concise review 2022: chronic obstructive pulmonary disease. Respirology 28:428\u2013436. https:\/\/doi.org\/10.1111\/resp.14489","journal-title":"Respirology"},{"key":"922_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/17476348.2025.2569126","volume":"20","author":"M Kallieri","year":"2026","unstructured":"Kallieri M, Hillas G, Bartziokas K, Loukides S, Toumpanakis D (2026) COPD and the burden of multimorbidity: navigating the complexity. Expert Rev Respir Med 20:251\u2013266. https:\/\/doi.org\/10.1080\/17476348.2025.2569126","journal-title":"Expert Rev Respir Med"},{"key":"922_CR5","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.2147\/COPD.S433183","volume":"18","author":"Y Qian","year":"2023","unstructured":"Qian Y, Cai C, Sun M, Lv D, Zhao Y (2023) Analyses of factors associated with acute exacerbations of chronic obstructive pulmonary disease: a review. Int J Chron Obstruct Pulmon Dis 18:2707\u20132723. https:\/\/doi.org\/10.2147\/COPD.S433183","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"922_CR6","doi-asserted-by":"publisher","first-page":"2599583","DOI":"10.1080\/15412555.2025.2599583","volume":"23","author":"A Voulgaris","year":"2026","unstructured":"Voulgaris A, Gogali A, Kostikas K, Steiropoulos P (2026) Management of COPD-OSA overlap syndrome beyond standard care. COPD 23:2599583. https:\/\/doi.org\/10.1080\/15412555.2025.2599583","journal-title":"COPD"},{"key":"922_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/resp.14334","volume":"27","author":"DM Mannino","year":"2022","unstructured":"Mannino DM, Tal-Singer R (2022) Long-term trends of COPD mortality: gaps and opportunities. Respirology 27:914\u2013915. https:\/\/doi.org\/10.1111\/resp.14334","journal-title":"Respirology"},{"key":"922_CR8","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/S0140-6736(17)31222-9","volume":"389","author":"KF Rabe","year":"2017","unstructured":"Rabe KF, Watz H (2017) Chronic obstructive pulmonary disease. Lancet 389:1931\u20131940. https:\/\/doi.org\/10.1016\/S0140-6736(17)31222-9","journal-title":"Lancet"},{"key":"922_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","volume":"11","author":"KM Olsson","year":"2023","unstructured":"Olsson KM, Corte TJ, Kamp JC, Montani D, Nathan SD, Neubert L, Price LC, Kiely DG (2023) Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management. Lancet Respir Med 11:820\u2013835. https:\/\/doi.org\/10.1016\/S2213-2600(23)00259-X","journal-title":"Lancet Respir Med"},{"key":"922_CR10","doi-asserted-by":"publisher","first-page":"1275684","DOI":"10.3389\/fmed.2023.1275684","volume":"10","author":"AA Alqarni","year":"2023","unstructured":"Alqarni AA, Aldhahir AM, Alghamdi SA, Alqahtani JS, Siraj RA, Alwafi H, AlGarni AA, Majrshi MS, Alshehri SM, Pang L (2023) Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD. Front Med (Lausanne) 10:1275684. https:\/\/doi.org\/10.3389\/fmed.2023.1275684","journal-title":"Front Med (Lausanne)"},{"key":"922_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.niox.2022.08.004","volume":"128","author":"G Giuriato","year":"2022","unstructured":"Giuriato G, Paneroni M, Venturelli M, Layec G (2022) Strategies targeting the NO pathway to counteract extra-pulmonary manifestations of COPD: A systematic review and meta-analysis. Nitric Oxide 128:59\u201371. https:\/\/doi.org\/10.1016\/j.niox.2022.08.004","journal-title":"Nitric Oxide"},{"key":"922_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pupt.2014.07.004","volume":"29","author":"LL Dupont","year":"2014","unstructured":"Dupont LL, Glynos C, Bracke KR, Brouckaert P, Brusselle GG (2014) Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases. Pulm Pharmacol Ther 29:1\u20136. https:\/\/doi.org\/10.1016\/j.pupt.2014.07.004","journal-title":"Pulm Pharmacol Ther"},{"key":"922_CR13","doi-asserted-by":"publisher","first-page":"1641932","DOI":"10.3389\/fphar.2025.1641932","volume":"16","author":"AA Alqarni","year":"2025","unstructured":"Alqarni AA, Alghamdi SA, Aldhahir AM, Alqahtani JS, Siraj RA, Alasimi AH, Bintalib HM, AlGarni AA, Majrshi M, Alshabasy AM, AlBahrani S, Alwafi H (2025) Drugs targeting the NO-sGC-cGMP pathway in the treatment of patients with COPD-associated pulmonary hypertension: a systematic review. Front Pharmacol 16:1641932. https:\/\/doi.org\/10.3389\/fphar.2025.1641932","journal-title":"Front Pharmacol"},{"key":"922_CR14","doi-asserted-by":"publisher","unstructured":"Antus B, Barta I (2022) Blood eosinophils and exhaled nitric oxide: surrogate biomarkers of airway eosinophilia in stable COPD and exacerbation. Biomedicines 10:2128. https:\/\/doi.org\/10.3390\/biomedicines10092128","DOI":"10.3390\/biomedicines10092128"},{"key":"922_CR15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1183\/20734735.0268-2019","volume":"15","author":"SW Turner","year":"2019","unstructured":"Turner SW, Chang AB, Yang IA (2019) Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD. Breathe (Sheff) 15:306\u2013316. https:\/\/doi.org\/10.1183\/20734735.0268-2019","journal-title":"Breathe (Sheff)"},{"key":"922_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2147\/COPD.S106480","volume":"11","author":"B Hajian","year":"2016","unstructured":"Hajian B, De Backer J, Vos W, Van Holsbeke C, Ferreira F, Quinn DA, Hufkens A, Claes R, De Backer W (2016) Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension. Int J Chron Obstruct Pulmon Dis 11:1533\u20131541. https:\/\/doi.org\/10.2147\/COPD.S106480","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"922_CR17","doi-asserted-by":"publisher","first-page":"1271342","DOI":"10.3389\/fimmu.2023.1271342","volume":"14","author":"LDN Camargo","year":"2023","unstructured":"Camargo LDN, Righetti RF, de Almeida FM, Dos Santos TM, Fukuzaki S, Martins NAB, Barbeiro MC, Saraiva-Romanholo BM, Lopes F, Leick EA, Prado CM, Tiberio I (2023) Modulating asthma-COPD overlap responses with IL-17 inhibition. Front Immunol 14:1271342. https:\/\/doi.org\/10.3389\/fimmu.2023.1271342","journal-title":"Front Immunol"},{"key":"922_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-6627-3_1","volume":"788","author":"A Holownia","year":"2013","unstructured":"Holownia A, Mroz RM, Wielgat P, Skopinski T, Kolodziejczyk A, Sitko A, Chyczewska E, Braszko JJ (2013) Altered histone deacetylase activity and iNOS expression in cells isolated from induced sputum of COPD patients treated with tiotropium. Adv Exp Med Biol 788:1\u20136. https:\/\/doi.org\/10.1007\/978-94-007-6627-3_1","journal-title":"Adv Exp Med Biol"},{"key":"922_CR19","doi-asserted-by":"publisher","first-page":"e1702","DOI":"10.1002\/ctm2.1702","volume":"14","author":"D Zhou","year":"2024","unstructured":"Zhou D, Liu C, Wang L, Li J, Zhao Y, Deng Z, Hou C, Fu Y, Jiang Q, Lai N, Zhang R, Feng W, Gao C, Li X, Jiang M, Fu X, Chen J, Hong W, Xu L, He W, Liu J, Yang Y, Lu W, Zhong N, Cao Y, Wang J, Chen Y (2024) Prediction of clinical risk assessment and survival in chronic obstructive pulmonary disease with pulmonary hypertension. Clin Transl Med 14:e1702. https:\/\/doi.org\/10.1002\/ctm2.1702","journal-title":"Clin Transl Med"},{"key":"922_CR20","doi-asserted-by":"publisher","unstructured":"Vazquez-Gandullo E, Hidalgo-Molina A, Montoro-Ballesteros F, Morales-Gonzalez M, Munoz-Ramirez I, Arnedillo-Munoz A (2022) Inspiratory muscle training in patients with chronic obstructive pulmonary disease (COPD) as Part of a respiratory rehabilitation program implementation of mechanical devices: a systematic review. Int J Environ Res Public Health 19:5564. https:\/\/doi.org\/10.3390\/ijerph19095564","DOI":"10.3390\/ijerph19095564"},{"key":"922_CR21","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.7150\/ijbs.109261","volume":"21","author":"X Yu","year":"2025","unstructured":"Yu X, Xiao H, Liu Y, Dong Z, Meng X, Wang F (2025) The Lung-Brain axis in chronic obstructive pulmonary disease-associated neurocognitive dysfunction: mechanistic insights and potential therapeutic options. Int J Biol Sci 21:3461\u20133477. https:\/\/doi.org\/10.7150\/ijbs.109261","journal-title":"Int J Biol Sci"},{"key":"922_CR22","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2147\/COPD.S424712","volume":"18","author":"J Yu","year":"2023","unstructured":"Yu J, Huang S, Shen W, Zhang Z, Ye S, Chen Y, Yang Y, Bian T, Wu Y (2023) Expression Profiles of circRNAs and Identification of hsa_circ_0007608 and hsa_circ_0064656 as Potential Biomarkers for COPD-PH Patients. Int J Chron Obstruct Pulmon Dis 18:2457\u20132471. https:\/\/doi.org\/10.2147\/COPD.S424712","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"922_CR23","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1080\/15384101.2020.1831246","volume":"19","author":"M Xiong","year":"2020","unstructured":"Xiong M, Guo M, Huang D, Li J, Zhou Y (2020) TRPV1 genetic polymorphisms and risk of COPD or COPD combined with PH in the Han Chinese population. Cell Cycle 19:3066\u20133073. https:\/\/doi.org\/10.1080\/15384101.2020.1831246","journal-title":"Cell Cycle"},{"key":"922_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/copd.s1170","volume":"3","author":"J Elwing","year":"2008","unstructured":"Elwing J, Panos RJ (2008) Pulmonary hypertension associated with COPD. Int J Chron Obstruct Pulmon Dis 3:55\u201370. https:\/\/doi.org\/10.2147\/copd.s1170","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"922_CR25","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.7150\/thno.99237","volume":"14","author":"J Jiang","year":"2024","unstructured":"Jiang J, Zheng Z, Chen S, Liu J, Jia J, Huang Y, Liu Q, Cheung CY, Sin DD, Yang T, Wang C (2024) Hypoxia inducible factor (HIF) 3alpha prevents COPD by inhibiting alveolar epithelial cell ferroptosis via the HIF-3alpha-GPx4 axis. Theranostics 14:5512\u20135527. https:\/\/doi.org\/10.7150\/thno.99237","journal-title":"Theranostics"},{"key":"922_CR26","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1161\/ATVBAHA.124.321780","volume":"45","author":"T Albendea-Gomez","year":"2025","unstructured":"Albendea-Gomez T, Mendoza-Tamajon S, Castro-Mecinas R, Escobar B, Ferreira Rocha S, Urra-Balduz S, Nicolas-Avila JA, Oliver E, Villalba-Orero M, Martin-Puig S (2025) Vascular HIF2 signaling prevents cardiomegaly, alveolar congestion, and capillary remodeling during chronic hypoxia. Arterioscler Thromb Vasc Biol 45:e78\u2013e98. https:\/\/doi.org\/10.1161\/ATVBAHA.124.321780","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"922_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12890-022-01958-4","volume":"22","author":"G Hoult","year":"2022","unstructured":"Hoult G, Gillespie D, Wilkinson TMA, Thomas M, Francis NA (2022) Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis. BMC Pulm Med 22:194. https:\/\/doi.org\/10.1186\/s12890-022-01958-4","journal-title":"BMC Pulm Med"},{"key":"922_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cell.2011.08.035","volume":"147","author":"M Seimetz","year":"2011","unstructured":"Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, Weisel FC et al (2011) Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell 147:293\u2013305. https:\/\/doi.org\/10.1016\/j.cell.2011.08.035","journal-title":"Cell"},{"key":"922_CR29","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1183\/09031936.02.00245902","volume":"19","author":"S Santos","year":"2002","unstructured":"Santos S, Peinado VI, Ramirez J, Melgosa T, Roca J, Rodriguez-Roisin R, Barbera JA (2002) Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J 19:632\u2013638. https:\/\/doi.org\/10.1183\/09031936.02.00245902","journal-title":"Eur Respir J"},{"key":"922_CR30","doi-asserted-by":"publisher","first-page":"2101153","DOI":"10.1183\/13993003.01153-2021","volume":"59","author":"M Gredic","year":"2022","unstructured":"Gredic M, Wu CY, Hadzic S, Pak O, Savai R, Kojonazarov B et al (2022) Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice. Eur Respir J 59:2101153. https:\/\/doi.org\/10.1183\/13993003.01153-2021","journal-title":"Eur Respir J"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00922-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:23:35Z","timestamp":1787045015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-026-00922-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00922-x","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective observational study was approved by Tianjin Chest Hospital (#2024KY-025-01), and informed written consent was waived.","order":3,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"61"}}